Search Results - "Lewis, Kriste A."

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2

    S Phase and G2 Arrests Induced by Topoisomerase I Poisons Are Dependent on ATR Kinase Function by Cliby, William A, Lewis, Kriste A, Lilly, Kia K, Kaufmann, Scott H

    Published in The Journal of biological chemistry (11-01-2002)
    “…ATR, a human phosphatidylinositol 3-kinase-related kinase, is an important component of the cellular response to DNA damage. In the present study, we evaluated…”
    Get full text
    Journal Article
  3. 3

    Ataxia telangiectasia and rad3-related kinase contributes to cell cycle arrest and survival after cisplatin but not oxaliplatin by Lewis, Kriste A, Lilly, Kia K, Reynolds, Evelyn A, Sullivan, William P, Kaufmann, Scott H, Cliby, William A

    Published in Molecular cancer therapeutics (01-04-2009)
    “…The DNA cross-linking agents cisplatin and oxaliplatin are widely used in the treatment of human cancer. Lesions produced by these agents are widely known to…”
    Get full text
    Journal Article
  4. 4

    Characteristics of Heart Rate Variability in Alcohol-Dependent Subjects and Nondependent Chronic Alcohol Users by Karpyak, Victor M., Romanowicz, Magdalena, Schmidt, John E., Lewis, Kriste A., Bostwick, John M.

    “…Heart rate variability (HRV) is an objective and sensitive measure of integrated physiological functioning reflective of heart rhythm responsivity to internal…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Müllerian inhibiting substance type II receptor (MISIIR): A novel, tissue-specific target expressed by gynecologic cancers by Bakkum-Gamez, Jamie N, Aletti, Giovanni, Lewis, Kriste A, Keeney, Gary L, Thomas, Bijoy M, Navarro-Teulon, Isabelle, Cliby, William A

    Published in Gynecologic oncology (01-01-2008)
    “…Abstract Objective. Müllerian inhibiting substance type II receptor (MISIIR) is expressed by ovarian, breast, and prostate cancers [Masiakos PT, et al. Human…”
    Get full text
    Journal Article
  7. 7

    Association of GATA4 sequence variation with alcohol dependence by Karpyak, Victor M., Winham, Stacey J., Biernacka, Joanna M., Cunningham, Julie M., Lewis, Kriste A., Geske, Jennifer R., Colby, Colin L., Abulseoud, Osama A., Hall-Flavin, Daniel K., Loukianova, Larissa L., Schneekloth, Terry D., Frye, Mark A., Heit, John A., Mrazek, David A.

    Published in Addiction biology (01-03-2014)
    “…To further explore reports of association of alcohol dependence and response to acamprosate treatment with the GATA4 rs13273672 single nucleotide polymorphism…”
    Get full text
    Journal Article
  8. 8

    Heterozygous ATR mutations in mismatch repair-deficient cancer cells have functional significance by LEWIS, Kriste A, MULLANY, Sally, THOMAS, Bijoy, CHIEN, Jeremy, LOEWEN, Ralitsa, SHRIDHAR, Viji, CLIBY, William A

    Published in Cancer research (Chicago, Ill.) (15-08-2005)
    “…ATR (ataxia telangiectasia and Rad3-related) function is necessary for the proper response to commonly used chemotherapeutic agents. Heterozygous truncating…”
    Get full text
    Journal Article
  9. 9

    Lovastatin alters the isoprenoid biosynthetic pathway in acute myelogenous leukemia cells in vivo by Lewis, Kriste A., Holstein, Sarah A., Hohl, Raymond J.

    Published in Leukemia research (01-05-2005)
    “…Lovastatin, a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase (HMGR), is used therapeutically to lower plasma cholesterol levels and has…”
    Get full text
    Journal Article
  10. 10

    Mutations in the ataxia telangiectasia and rad3-related-checkpoint kinase 1 DNA damage response axis in colon cancers by Lewis, Kriste A., Bakkum-Gamez, Jamie, Loewen, Ralitsa, French, Amy J., Thibodeau, Stephen N., Cliby, William A.

    Published in Genes chromosomes & cancer (01-12-2007)
    “…In response to certain types of DNA damage, ataxia telangiectasia and rad3‐related (ATR) phosphorylates checkpoint kinase 1 (CHEK1) resulting in cell cycle…”
    Get full text
    Journal Article
  11. 11

    A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days by BAILEY, Howard H, WILDING, George, LEWIS, Kriste A, HOHL, Raymond J, TUTSCH, Kendra D, ARZOOMANIAN, Rhoda Z, ALBERTI, Dona, FEIERABEND, Chris, SIMON, Kris, MARNOCHA, Rebecca, HOLSTEIN, Sarah A, STEWART, Jan

    Published in Cancer chemotherapy and pharmacology (01-10-2004)
    “…Perillyl alcohol (POH) has been shown to have both chemopreventative and chemotherapeutic activities in preclinical studies. The underlying mechanism(s) of…”
    Get full text
    Journal Article
  12. 12

    Stereochemistry‐dependent inhibition of RAS farnesylation by farnesyl phosphonic acids by Hohl, Raymond J., Lewis, Kriste A., Cermak, Diana M., Wiemer, David F.

    Published in Lipids (01-01-1998)
    “…This investigation compares the effects of three farnesyl pyrophosphate analogs on selected aspects of isoprenoid metabolism. E,E‐α‐Hydroxyfarnesylphosphonate…”
    Get full text
    Journal Article
  13. 13

    ATR CONTRIBUTES TO CELL CYCLE ARREST AND SURVIVAL AFTER CISPLATIN BUT NOT OXALIPLATIN1 by Lewis, Kriste A., Lilly, Kia K., Reynolds, Evelyn A., Sullivan, William P., Kaufmann, Scott H., Cliby, William A.

    Published in Molecular cancer therapeutics (01-04-2009)
    “…The DNA cross-linking agents cisplatin and oxaliplatin are widely used in the treatment of human cancer. Lesions produced by these agents are widely known to…”
    Get full text
    Journal Article
  14. 14